Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Always Active
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

REQUEST FOR PROPOSAL for the provision of advice and support to GARDP Foundation in the definition of the evolution of its operational model in the coming five years.

Closing date: 03.03.2025

ABOUT GARDP FOUNDATION

The Global Antibiotic Research & Development Partnership (GARDP Foundation) is a not-for-profit global health organization seated in Geneva, Switzerland. GARDP Foundation’s mission is to accelerate the development of, and access to, treatments for drug-resistant bacterial infections. It does so by forging public-private partnerships all over the world to develop and expand access to treatments for serious bacterial infections and sepsis in adults, children and newborns, as well as sexually transmitted infections (STIs).
GARDP Foundation responds to the crisis in antimicrobial resistance. In 2015, the World Health Assembly, the decision-making body of the World Health Organization (WHO), adopted the Global Action Plan on Antimicrobial Resistance. The following year, to deliver on this plan, WHO and the Drugs for Neglected Diseases initiative created GARDP Foundation. In 2018, it was legally established as an independent entity.
Since then, GARDP Foundation has developed a portfolio of antibiotic treatments targeting WHO priority pathogens, priority diseases and key populations/regions that are especially affected by antibiotic resistance. It is also pioneering new access initiatives with innovator, manufacturing and distribution partners.
As of 2025, GARDP Foundation’s team consists of about 100 people who collectively share extensive cross-sector R&D, access, business development and other relevant experience. They work with the key public and private sector stakeholders and partners, such as the research and development community, donors, industry and implementing countries.

If you are interested to receive the complete documentation, please review, complete and sign that attached confidential framework and send it to: RFP_Procurement@gardp.org.

 

Due/closing date: March 3rd 2025